These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10973288)

  • 1. Re-evaluating sarcoplasmic reticulum function in heart failure.
    Delling U; Sussman MA; Molkentin JD
    Nat Med; 2000 Sep; 6(9):942-3. PubMed ID: 10973288
    [No Abstract]   [Full Text] [Related]  

  • 2. Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy.
    Haghighi K; Gregory KN; Kranias EG
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1214-22. PubMed ID: 15336969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sarcoplasmic reticulum function and heart failure: a novel therapeutic target for heart failure].
    Minamisawa S; Ikeda Y
    Clin Calcium; 2006 Jan; 16(1):37-44. PubMed ID: 16397349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Function and role of the sarcoplasmic reticulum in heart disease].
    Reyes-Juárez JL; Zarain-Herzberg A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S18-32. PubMed ID: 17469332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholamban: a key determinant of cardiac function and dysfunction.
    Rodriguez P; Kranias EG
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1239-43. PubMed ID: 16435604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholamban: a crucial regulator of cardiac contractility.
    MacLennan DH; Kranias EG
    Nat Rev Mol Cell Biol; 2003 Jul; 4(7):566-77. PubMed ID: 12838339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of the calcium ATPase with phospholamban and sarcolipin: structure, physiology and pathophysiology.
    Maclennan DH
    J Muscle Res Cell Motil; 2004; 25(8):600-1. PubMed ID: 16118852
    [No Abstract]   [Full Text] [Related]  

  • 8. Phospholamban and cardiac contractile function.
    Brittsan AG; Kranias EG
    J Mol Cell Cardiol; 2000 Dec; 32(12):2131-9. PubMed ID: 11112989
    [No Abstract]   [Full Text] [Related]  

  • 9. SERCA upregulation: breaking the positive feedback in heart failure?
    Bassani JW; Bassani RA
    Cardiovasc Res; 2005 Sep; 67(4):581-2. PubMed ID: 16018992
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of calcium cycling defects in advanced heart failure toward molecular therapy.
    Hoshijima M; Knöll R; Pashmforoush M; Chien KR
    J Am Coll Cardiol; 2006 Nov; 48(9 Suppl 1):A15-23. PubMed ID: 17084280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of regucalcin as an activator of sarcoplasmic reticulum Ca2+-ATPase activity in rat heart muscle.
    Yamaguchi M; Nakajima R
    J Cell Biochem; 2002; 86(1):184-93. PubMed ID: 12112029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
    Ai X; Curran JW; Shannon TR; Bers DM; Pogwizd SM
    Circ Res; 2005 Dec; 97(12):1314-22. PubMed ID: 16269653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcoplasmic reticulum Ca2+ refilling controls recovery from Ca2+-induced Ca2+ release refractoriness in heart muscle.
    Szentesi P; Pignier C; Egger M; Kranias EG; Niggli E
    Circ Res; 2004 Oct; 95(8):807-13. PubMed ID: 15388639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excessive sarcoplasmic/endoplasmic reticulum Ca2+-ATPase expression causes increased sarcoplasmic reticulum Ca2+ uptake but decreases myocyte shortening.
    Teucher N; Prestle J; Seidler T; Currie S; Elliott EB; Reynolds DF; Schott P; Wagner S; Kogler H; Inesi G; Bers DM; Hasenfuss G; Smith GL
    Circulation; 2004 Dec; 110(23):3553-9. PubMed ID: 15505097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting sarcoplasmic reticulum calcium handling proteins as therapy for cardiac disease.
    Gregory KN; Kranias EG
    Hellenic J Cardiol; 2006; 47(3):132-43. PubMed ID: 16862819
    [No Abstract]   [Full Text] [Related]  

  • 16. Sarcoplasmic reticulum calcium overloading in junctin deficiency enhances cardiac contractility but increases ventricular automaticity.
    Yuan Q; Fan GC; Dong M; Altschafl B; Diwan A; Ren X; Hahn HH; Zhao W; Waggoner JR; Jones LR; Jones WK; Bers DM; Dorn GW; Wang HS; Valdivia HH; Chu G; Kranias EG
    Circulation; 2007 Jan; 115(3):300-9. PubMed ID: 17224479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca-ATPase, on skeletal muscles from normal and mdx mice.
    Divet A; Lompré AM; Huchet-Cadiou C
    Acta Physiol Scand; 2005 Jul; 184(3):173-86. PubMed ID: 15954985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of sarcoplasmic reticulum membranes.
    Martonosi A
    Annu Rev Physiol; 1982; 44():337-55. PubMed ID: 6462104
    [No Abstract]   [Full Text] [Related]  

  • 19. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sarcoplasmic reticulum proteins are targets for calpain action in the ischemic-reperfused heart.
    Singh RB; Chohan PK; Dhalla NS; Netticadan T
    J Mol Cell Cardiol; 2004 Jul; 37(1):101-10. PubMed ID: 15242740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.